About

David Huberman is a partner in the International Department of our Tel Aviv office, and a member of our Capital Markets and Finance practice groups.

David focuses on U.S. securities law and capital market transactions. He advises many technology and pharmaceutical companies and provides comprehensive legal counsel on all aspects of U.S. corporate and securities law, including public offerings. David provides ongoing advice to many Israeli companies listed on Nasdaq.

Representative Client Work

  • Represented Safe-T Group Ltd. in its U.S. IPO, including its dual listing on the Nasdaq Capital Market.
  • Represented Nano Dimension Ltd. in several public offering of American Depositary Shares.
  • Represented Foresight Autonomous Holdings Ltd. in the process of listing American Depositary Shares representing the company’s ordinary shares on the Nasdaq Capital Market.
  • Represented Foresight Autonomous Holdings Ltd. in a series of PIPE transactions.
  • Represented Nano Dimension Ltd. in a series of PIPE transactions.
  • Represented Therapix Biosciences Ltd. in its U.S. IPO, including its dual listing on the Nasdaq Capital Market.
  • Represented Radcom Ltd. in its public offering of ordinary shares.
  • Represented investment bank Rodman & Renshaw as an underwriter in a public offering.
  • Represented Nano Dimension Ltd. in the process of up-listing American Depositary Shares representing the company’s ordinary shares on the Nasdaq Capital Market.
  • Represented Radcom Ltd. in its public offering of ordinary shares.
  • Represented Alcobra Ltd. in several public offering of ordinary shares.
  • Represented Bioblast Pharma Ltd. in its registered direct offering of ordinary shares.
  • Represented On Track Innovations Ltd. in its public offering of ordinary shares.

Recent Activity